{"schema_version":"secwatch.filing_event.v1","accession":"0001539497-26-000812","form_type":"8-K","ticker":"BCAB","cik":"0001826892","company_name":"BioAtla, Inc.","filed_at":"2026-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.391448+00:00","generated_at":"2026-05-15T22:44:17.379257+00:00","sec_items":["2.02","7.01","2.05","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"BioAtla initiates strategic review, cuts 70% workforce; CFO replaced; cash ~$7.1M","bullets":["Workforce reduced ~70%; severance costs estimated $0.5-0.6M; committed Feb 24, 2026.","CFO Richard Waldron departs March 2; succeeded by Chief Accounting Officer Chris Vasquez.","Formal strategic review launched to monetize assets; Tungsten Advisors engaged as advisor.","Preliminary cash and cash equivalents $7.1M as of Dec 31, 2025; no PPA amounts outstanding.","Nasdaq delisting review ongoing; $40M SPV transaction with Inversagen AI not yet closed."],"urls":{"canonical":"https://secwatch.observer/filing/0001539497-26-000812","json":"https://secwatch.observer/filing/0001539497-26-000812.json","markdown":"https://secwatch.observer/filing/0001539497-26-000812.md","text":"https://secwatch.observer/filing/0001539497-26-000812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/n5620_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:44:17.379257+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a12514e93a9179944e3859e91d6e3c8cc90e842d","claim":"BioAtla, Inc. announced a restructuring with charges of between $0.5 and $0.6 million affecting the Company (approximately 70%).","evidence_excerpt":"formal process to explore and evaluate strategic options to maximize shareholder value. The total cash payments related to this workforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company expects to pay for the majority of these costs in the first quarter of 2026. The estimates of the","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001315257-26-000036","ticker":"KOP","company_name":"Koppers Holdings Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Koppers conditionally plans to shut Stickney, IL chemical operations; Q1 adjusted EPS down 19.7%","event_type":"other_material","sec_items":["2.02","2.05","5.02","5.07","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.02, 2.05, 5.02, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001315257-26-000036","json":"https://secwatch.observer/filing/0001315257-26-000036.json","markdown":"https://secwatch.observer/filing/0001315257-26-000036.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1315257/000131525726000036/0001315257-26-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1315257/000131525726000036/kop-20260507.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"formal process to explore and evaluate strategic options to maximize\nshareholder value. The total cash payments related to this\nworkforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company\nexpects to pay for the majority of these costs in the first quarter of 2026. The estimates of the","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","comparable_excerpt":"potentially appropriate uses for the Stickney facility following the end of production activities. The Company expects this action to result in pre-tax charges to earnings of $227 million to $262 million through the end of 2029, approximately $170 million to $195 million of which constitutes non-cash charges and approximately $57 million to $67 million of which","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1315257/000131525726000036/0001315257-26-000036-index.htm"}},{"accession":"0001104659-26-049837","ticker":"IAC","company_name":"IAC Inc.","filed_at":"2026-04-28T23:59:59+00:00","headline":"IAC announces name change to 'People Incorporated', restructuring with $40M cost savings, and C-suite changes","event_type":"other_material","sec_items":["2.02","7.01","2.05","5.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.02, 2.05, 5.02, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-049837","json":"https://secwatch.observer/filing/0001104659-26-049837.json","markdown":"https://secwatch.observer/filing/0001104659-26-049837.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800227/000110465926049837/0001104659-26-049837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800227/000110465926049837/tm2612831d1_8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"formal process to explore and evaluate strategic options to maximize\nshareholder value. The total cash payments related to this\nworkforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company\nexpects to pay for the majority of these costs in the first quarter of 2026. The estimates of the","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","comparable_excerpt":"Ahead of its name change to \"People Incorporated\" which is expected to occur with the release of Q2 2026 earnings in August, the Company has initiated a plan to consolidate its corporate functions with those of its People Inc. business (\" People \"), through a reduction in workforce, technology integrations, and other cost-saving measures over the coming quarters (the \" Plan \"). The Plan is expected to generate annual run-rate cost savings of approximately $40 million. The Plan is expected to be completed by Q1 of 2027. The Company expects to incur approximately $14 million in severance and related expenses, $48 million in non-cash stock-based compensation expense and $0.5 million to $1 million in other costs related to the Plan.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1800227/000110465926049837/0001104659-26-049837-index.htm"}},{"accession":"0001477333-26-000033","ticker":"NET","company_name":"Cloudflare, Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"Cloudflare Q1 revenue $639.8M +34% YoY; announces 20% workforce reduction","event_type":"other_material","sec_items":["2.02","2.05","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.02, 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001477333-26-000033","json":"https://secwatch.observer/filing/0001477333-26-000033.json","markdown":"https://secwatch.observer/filing/0001477333-26-000033.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477333/000147733326000033/0001477333-26-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477333/000147733326000033/cloud-20260507.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"formal process to explore and evaluate strategic options to maximize\nshareholder value. The total cash payments related to this\nworkforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company\nexpects to pay for the majority of these costs in the first quarter of 2026. The estimates of the","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","comparable_excerpt":"On May 7, 2026, the Company announced a plan (the “Plan”) designed to further accelerate its evolution to an agentic AI-first operating model. As part of the Plan, the Company expects to reduce its current workforce by approximately 20%. The Company currently estimates that it will incur charges of between $140 million and $150 million in connection with the Plan","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1477333/000147733326000033/0001477333-26-000033-index.htm"}},{"accession":"0001193125-26-155861","ticker":"SNAP","company_name":"Snap Inc","filed_at":"2026-04-15T23:59:59+00:00","headline":"Snap reports Q1 rev ~$1.53B (+12% YoY), adj EBITDA ~$233M; cuts 16% of staff (~1,000 jobs)","event_type":"other_material","sec_items":["2.02","2.05","7.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.02, 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-155861","json":"https://secwatch.observer/filing/0001193125-26-155861.json","markdown":"https://secwatch.observer/filing/0001193125-26-155861.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1564408/000119312526155861/0001193125-26-155861-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1564408/000119312526155861/d36756d8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"formal process to explore and evaluate strategic options to maximize\nshareholder value. The total cash payments related to this\nworkforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company\nexpects to pay for the majority of these costs in the first quarter of 2026. The estimates of the","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","comparable_excerpt":"increased operational efficiencies to accelerate our path toward net-income profitability. As a result, we currently estimate that we will incur pre-tax charges in the range of $95 million to $130 million, primarily consisting of severance and related costs, contract termination costs, and other impairment charges, of which $75 million to $100 million are expected","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1564408/000119312526155861/0001193125-26-155861-index.htm"}},{"accession":"0001650372-26-000021","ticker":"TEAM","company_name":"Atlassian Corp","filed_at":"2026-03-11T23:59:59+00:00","headline":"Atlassian to cut ~10% workforce (~1,600 roles); CTO Rajeev Rajan departing","event_type":"other_material","sec_items":["2.05","7.01","5.02","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 5.02, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001650372-26-000021","json":"https://secwatch.observer/filing/0001650372-26-000021.json","markdown":"https://secwatch.observer/filing/0001650372-26-000021.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650372/000165037226000021/0001650372-26-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650372/000165037226000021/team-20260311.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"formal process to explore and evaluate strategic options to maximize\nshareholder value. The total cash payments related to this\nworkforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company\nexpects to pay for the majority of these costs in the first quarter of 2026. The estimates of the","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","comparable_excerpt":"efficiency and sustainability. Position eliminations in each country are subject to local law and consultation requirements. The Company estimates it will incur approximately $225 million to $236 million in charges in connection with these actions, of which approximately $169 million to $174 million is expected to result in future cash outlays related to","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1650372/000165037226000021/0001650372-26-000021-index.htm"}},{"accession":"0001104659-26-022572","ticker":"TBPH","company_name":"Theravance Biopharma, Inc.","filed_at":"2026-03-03T23:59:59+00:00","headline":"Theravance Biopharma Phase 3 CYPRESS study fails; plans 50% workforce cut and strategic review","event_type":"other_material","sec_items":["2.02","2.05","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.02, 2.05, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-022572","json":"https://secwatch.observer/filing/0001104659-26-022572.json","markdown":"https://secwatch.observer/filing/0001104659-26-022572.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/tm267846d1_8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"formal process to explore and evaluate strategic options to maximize\nshareholder value. The total cash payments related to this\nworkforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company\nexpects to pay for the majority of these costs in the first quarter of 2026. The estimates of the","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","comparable_excerpt":"On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1583107/000110465926022572/0001104659-26-022572-index.htm"}},{"accession":"0001193125-26-031987","ticker":"IOBTQ","company_name":"IO Biotech, Inc.","filed_at":"2026-01-30T23:59:59+00:00","headline":"IO Biotech explores strategic alternatives, cuts workforce, CMO departs, hires Raymond James","event_type":"other_material","sec_items":["2.05","5.02","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 5.02, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-031987","json":"https://secwatch.observer/filing/0001193125-26-031987.json","markdown":"https://secwatch.observer/filing/0001193125-26-031987.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865494/000119312526031987/0001193125-26-031987-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865494/000119312526031987/d13704d8k.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"formal process to explore and evaluate strategic options to maximize\nshareholder value. The total cash payments related to this\nworkforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company\nexpects to pay for the majority of these costs in the first quarter of 2026. The estimates of the","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","comparable_excerpt":"As part of previously announced efforts by IO Biotech, Inc. (the “Company”) to reduce the Company’s operating expenses while the Company explores a range of strategic alternatives, the Board of Directors of the Company approved on January 21, 2026, a restructuring and workforce reduction plan (the “Plan”) which is expected to result in a significant reduction of the Company’s workforce globally. In connection with the implementation of the Plan, the Company expects to incur one-time charges and cash expenditures in a range of approximately $2.4 million to $2.6 million, primarily related to employee wages and severance payments, healthcare continuation, earned vacation time and related termination costs.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1865494/000119312526031987/0001193125-26-031987-index.htm"}},{"accession":"0001802457-26-000021","ticker":"ORGN","company_name":"Origin Materials, Inc.","filed_at":"2026-05-01T23:59:59+00:00","headline":"Origin Materials board approves dissolution, liquidation; CEO steps down; workforce cut 59%","event_type":"other_material","sec_items":["2.05","5.02","9.01"],"materiality_score":0.95,"calibrated_materiality_score":0.95,"match_reasons":["same fact type: restructuring_charge","same SEC item: 2.05, 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001802457-26-000021","json":"https://secwatch.observer/filing/0001802457-26-000021.json","markdown":"https://secwatch.observer/filing/0001802457-26-000021.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/orgn-20260501.htm"},"side_by_side_evidence":{"fact_type":"restructuring_charge","source_excerpt":"formal process to explore and evaluate strategic options to maximize\nshareholder value. The total cash payments related to this\nworkforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company\nexpects to pay for the majority of these costs in the first quarter of 2026. The estimates of the","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1826892/000153949726000812/0001539497-26-000812-index.htm","comparable_excerpt":"its workforce by approximately 59%, resulting in an approximately $14.0 million decrease in annual operating expenses. Origin anticipates that it will incur approximately $2.1 million in restructuring charges in connection with the workforce reduction, primarily consisting of cash expenditures of approximately $2.1 million for severance and benefits costs.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1802457/000180245726000021/0001802457-26-000021-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}